Login / Signup

International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg-1 per day starting dose of oral corticosteroids to treat bullous pemphigoid.

Vivien HébertS BastosK DrenovskaJ MeijerSaskia Ingen Housz OroChristophe BedaneL LunardonSébastien DebarbieuxH JedlickovaF CauxGuillaume ChabyMichel D'IncanClaudio FelicianiC BoulardN SchumacherE SchmidtA RousselM A RichardJ GottliebV FerrantiO GuérinJ BénichouP Jolynull null
Published in: The British journal of dermatology (2021)
A 0·5 mg kg-1 per day dose of prednisone is a valuable therapeutic option in patients with mild or moderate BP whose general condition allows them to be autonomous.
Keyphrases
  • clinical trial
  • study protocol
  • high intensity
  • cross sectional